-
Loading metrics
Open Access
Peer-reviewed
Research Article
Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is a novel target of lung cancer stem-like cell immunotherapy
-
Ryota Horibe,
Affiliations Department of Pathology, Sapporo Medical University School of Medicine, Japan, Department of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, Japan
⨯ -
Yoshihiko Hirohashi ,
* E-mail: torigoe@sapmed.ac.jp(TT); hirohash@sapmed.ac.jp (YH)
Affiliation Department of Pathology, Sapporo Medical University School of Medicine, Japan
⨯ -
Takuya Asano,
Affiliations Department of Pathology, Sapporo Medical University School of Medicine, Japan, Department of Obstetrics and Gynecology, Sapporo Medical University School of Medicine, Japan
⨯ -
Tasuku Mariya,
Affiliations Department of Pathology, Sapporo Medical University School of Medicine, Japan, Department of Obstetrics and Gynecology, Sapporo Medical University School of Medicine, Japan
⨯ -
Takeshi Suzuki,
Affiliation Department of Biology, Sapporo Medical University School of Medicine, Japan
⨯ -
Akari Takaya,
Affiliation Department of Pathology, Sapporo Medical University School of Medicine, Japan
⨯ -
Hiroshi Saijo,
Affiliations Department of Pathology, Sapporo Medical University School of Medicine, Japan, Department of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, Japan
⨯ -
Yosuke Shionoya,
Affiliations Department of Pathology, Sapporo Medical University School of Medicine, Japan, Department of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, Japan
⨯ -
Terufumi Kubo,
Affiliation Department of Pathology, Sapporo Medical University School of Medicine, Japan
⨯ -
Munehide Nakatsugawa,
Affiliation Department of Pathology, Sapporo Medical University School of Medicine, Japan
⨯ -
Takayuki Kanaseki,
Affiliation Department of Pathology, Sapporo Medical University School of Medicine, Japan
⨯ -
Tomohide Tsukahara,
Affiliation Department of Pathology, Sapporo Medical University School of Medicine, Japan
⨯ -
Kazue Watanabe,
Affiliations Department of Pathology, Sapporo Medical University School of Medicine, Japan, MEDICAL and BIOLOGICAL LABORATORIES CO., LTD., Japan
⨯ -
Eri Atsuyama,
Affiliation MEDICAL and BIOLOGICAL LABORATORIES CO., LTD., Japan
⨯ -
Shingo Toji,
Affiliation MEDICAL and BIOLOGICAL LABORATORIES CO., LTD., Japan
⨯ -
Hiroshi Hirano,
Affiliation Department of Surgical Pathology, Sapporo Medical University School of Medicine, Japan
⨯ -
Tadashi Hasegawa,
Affiliation Department of Surgical Pathology, Sapporo Medical University School of Medicine, Japan
⨯ -
Hiroki Takahashi,
Affiliation Department of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, Japan
⨯ -
Noriyuki Sato,
Affiliation Department of Pathology, Sapporo Medical University School of Medicine, Japan
⨯ - [ ... ],
-
Toshihiko Torigoe
* E-mail: torigoe@sapmed.ac.jp(TT); hirohash@sapmed.ac.jp (YH)
Affiliation Department of Pathology, Sapporo Medical University School of Medicine, Japan
⨯ - [ view all ]
- [ view less ]
Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is a novel target of lung cancer stem-like cell immunotherapy
- Ryota Horibe,
- Yoshihiko Hirohashi,
- Takuya Asano,
- Tasuku Mariya,
- Takeshi Suzuki,
- Akari Takaya,
- Hiroshi Saijo,
- Yosuke Shionoya,
- Terufumi Kubo,
- Munehide Nakatsugawa
- Published: March 1, 2017
- https://doi.org/10.1371/journal.pone.0171460